Retatrutide, a experimental dual stimulator of the GLP-1 receptor and glucose-dependent secreted polypeptide (GIP) receptor , is showing promising outcomes in early patient trials . Ongoing research https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/